Arm latest to halt dealings with Huawei
[ Min Choi 2019-05-23 ]  
Email
Print


UK-based chip designer Arm reportedly became the latest company to suspend business with Huawei, in what would be the biggest blow yet to the Chinese vendor.

BBC News reported it obtained internal documents in which Arm instructed its employees to halt all active contracts, support and "any pending engagements with Huawei", to comply with a recent US ban against the company.

Arm, which was acquired by Japan-based SoftBank in 2016, is headquartered in the UK but employs 6,000 workers across eight offices in the US.

In its note to staff, Arm said its products contain "US origin technology", meaning it has a duty to comply with the ban.

If true, Arm's decision could have crippling affects on Huawei's smartphone business, as it would impact the company's capabilities to develop its own mobile chips.

While Arm does not manufacture chips, it provides technology vital to the running of processors under licence.

Huawei sources some of its mobile chips from HiSilicon, which it owns. But HiSilicon's chips, including Huawei's forthcoming Kirin 985 processor, are built using Arm's technology.

The Kirin 985, which is to be used in upcoming Huawei devices is not expected to be affected by Arm's ban, BBC News stated, but a source said the next iteration of the chip may have to be built from scratch.

In a tumultuous week already for the vendor and its smartphone business, Google said it will Limit Huawei's use of its Android operating system and other services.

Global News Network 'AVING'
by Min Choi (www.aving.net)

Copyright ⓒ 2020 AVING. All Rights Reserved.   메일보내기 인쇄하기
  AVING Around the World  
    latest Mobile/Computing
Major innovation companies of KHIDI Health Industry Startup I... 2020-05-07
A total of six companies participated in the MIK Hot Spot_KHIDI Health Industry Startup Innovation Center. △ PDxen △ G
[MIK HOT SPOT_KHIDI] Jeios's smart immunity analysis predicti... 2020-05-07
Although the mortality rate of COVID-19 is low compared to SARS and MERS, the spread rate is known to be as fast as the
[MIK HOT SPOT_KHIDI] Immunomax presents self-memory T cell-ba... 2020-05-07
Immunomax, which participated in MIK Hot Spot (Made in Korea Online Exhibition) KHIDI introduced its self-memory T cell-
[MIK HOT SPOT_KHIDI] Genome & Company on its establishment, s... 2020-05-07
Genome & Company was listed in KONEX in just three years and attracted Series C investment in just five years of bus
[MIK HOT SPOT_KHIDI] Damage in mitochondria causes disease! P... 2020-05-07
Paean Biotechnology is developing anti-inflammatory and anti-cancer drugs based on mitochondria separated from human umb
 
     
   
     

 
Copyright ⓒ 2020 AVING. All Rights Reserved.  Contact Webmaster for more Information